Why too many women are prescribed antibiotics for UTIs they don't have

A new study is raising questions about a familiar explanation for persistent urinary symptoms in women: recurring urinary tract infections. The research indicates that a sizeable share of women repeatedly treated for UTIs may have been given the wrong label. Rather than an infection returning again and again, their discomfort may be linked to inflammation shaped by hormonal changes and to problems involving the pelvic floor.

The distinction matters because the usual story can become self-reinforcing. A patient reports symptoms associated with a UTI, receives a diagnosis, takes antibiotics, and later experiences similar symptoms. Another course may follow. When the pattern continues, the repeated treatment can make it seem as though an infection has proved unusually stubborn, even when infection is not the underlying reason for the symptoms.

In clinical use, recurrent UTI has a specific threshold: two episodes within six months, or three during a year. That definition describes the frequency of diagnoses, not necessarily a final explanation for every episode of urinary discomfort. The study’s findings point to the importance of separating a repeated diagnostic pattern from the cause of the symptoms that brought someone back for care.

Maria Uloko, a urologist practicing in Los Angeles, said this is a common presentation in her work. She sees women who have accumulated several antibiotic treatments after being told they have recurrent UTIs, yet remain unsure why the problem appears to keep returning. For many, the central frustration is not simply discomfort; it is the lack of a clear account of why treatment has not ended the cycle.

Uloko tells some of those patients that the diagnosis they have repeatedly received may not fit their condition. In the study described in the report, hormonally related inflammation and pelvic floor dysfunction emerged as alternative explanations for symptoms that had been attributed to bladder infections. Those possibilities can produce a different medical conversation from one focused solely on preventing another presumed infection.

The findings do not mean that recurring UTIs are unreal or that every woman with urinary symptoms has been misdiagnosed. They do, however, challenge the assumption that recurrence automatically establishes the explanation. A frequency-based diagnosis can coexist with uncertainty about the mechanism behind symptoms, particularly when patients continue to seek care despite repeated rounds of the same treatment.

The potential scale is significant. Uloko said millions of women may be receiving antibiotics for suspected UTIs that they do not actually have. That estimate frames the issue as more than an individual diagnostic puzzle. It also raises broader questions about how persistent symptoms are assessed, how often a prior diagnosis guides later decisions, and whether other contributors are being considered early enough.

The report’s central warning is about diagnostic momentum: once a woman has been classified as having recurrent UTIs, later episodes of similar symptoms can be interpreted through that earlier conclusion. The study suggests that this path can obscure conditions that require a different explanation. It does not settle the cause of symptoms in any particular patient, nor does it turn every prior UTI diagnosis into an error. Instead, it identifies a group of women for whom the infection-centered account may be incomplete.

For patients who have been caught in this cycle, the study offers both a possible explanation and a reason for caution. Learning that symptoms may stem from hormones or pelvic floor function can be clarifying after repeated unsuccessful treatment. It can also be upsetting to realize that earlier care may have pursued the wrong problem. The study does not prescribe a single response, but it shifts the question clinicians and patients may need to ask: not only how to stop another infection, but whether infection is the right explanation at all. That uncertainty is the issue the study brings into sharper focus.

Source: NPR Health